Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of STK4 mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of STK4 mRNA | decreases expression | 20018196 19150397
|
D005472 |
Fluorouracil |
STK4 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] | affects cotreatment|affects response to substance | 18927307
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of STK4 mRNA | decreases expression | 18927307
|
C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of STK4 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in decreased expression of STK4 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
STK4 protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] | affects cotreatment|affects response to substance | 18927307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of STK4 mRNA | increases expression | 12377990
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of STK4 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.48 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
9.71 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.71 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.03 | 15136595 16110121 18608205 16557594 16595493 18357371 19217205 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.35 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.19 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
9.04 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
9.04 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.20 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.20 | 16332177 16799960 17045692 17088986 18930000 17971768 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.14 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.56 | 17066447 16757204 16280240 18986760 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.93 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 16354765 15668235 8697196 15340226 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
4.12 | 17169374 17287894 17016597 18772588 17018589 17172411 16510598 17725105 16340194 15001691 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
4.12 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.79 | 16524972 17016601 17695437 16331619 16282729 18802399 18448328 18949393 16391804 20501625 17094418 17255274 17454858 18288408 16303861 14970324 18383874 17401013 15148649 17594712 18509181 15289873 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.79 | 18509181 17159606 16303861 15273666 16391804 18259882 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.55 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.55 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.43 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.25 | 16733453 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.95 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.95 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.22 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.73 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.73 | 15173087 16481741 16785472 17638652 16337965 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.97 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.59 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
7.06 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
7.06 | 16080930 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 12621046 16120746 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.79 | 16863852 16490937 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.49 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 18606429 15340226 8697196 16354765 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.99 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
4.73 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.96 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.39 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.39 | 16985049 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.42 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.42 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
4.82 | 18383874 15113037 16603448 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.82 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.37 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.58 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.58 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
3.58 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.25 | 15086387 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.87 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.47 | 17159606 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.32 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.27 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.74 | 18239605 18600527 16928823 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.62 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.19 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.64 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.73 | 12819281 16049721 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.75 | 19003803 15113037 16500647 16929163 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11399792 11896295 11222880 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.28 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.28 | 15084515 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.30 | 18286688 16160472 15538739 18722050 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.73 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.50 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.77 | 19084572 17498489 17522103 19015929 16424979 16951190 15786421 18567086 17172411 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.77 | 15723263 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.77 | 16517955 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.29 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.38 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.78 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.18 | 16803524 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |